More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research
Wellesley, Mass. (PRWEB) July 07, 2015 -- An aging population, an increase of chronic diseases, and a growing demand for biologic are some of the factors driving the pharmaceutical contract manufacturing market. BCC Research reveals in its new report that the strategies of drug manufacturers, as well as contract manufacturing organizations (CMOs), are driving market growth. Drug manufacturers are increasing their outsourcing budgets and CMOs are developing capabilities and expanding their capacity to meet client needs.
The report analyzes four segments of the global contract pharmaceutical market: over-the-counter and nutraceuticals, bulk and dosage form drugs, research, and packaging. In 2014, the global revenue for contract research, the fastest growing segment, totaled $42 billion. From a predicted five-year compound annual growth (CAGR) of 11.5%, this segment should reach $72 billion in 2019. North America and Europe are the leading markets for contract research.
The largest segment of the overall market, OTC and nutraceuticals, totaled $138.7 billion in 2014 and should reach $192.3 billion in 2019, reflecting a CAGR of 6.8%. Factors driving market growth include the trend towards self-medication and a growing geriatric population.
In recent years, many organizations have taken advantage of contract manufacturing, contract research and contract packaging. The companies involved in the contract process have benefited from the alliance as it provides the manufacturing/research/packaging company with financial stability for the duration of the contract, while the hiring company benefits by saving costs and eliminating the stresses related to operating and managing a production facility and related research.
“Pharmaceutical outsourcing has become a viable business strategy that is enabling pharmaceutical firms to transfer non-core activities to external CMO partners in order to restructure their distribution networks, leverage resources, spread out risk, focus on issues imperative to survival, achieve competitive advantage and assures future growth,” says BCC Research analyst Shalini S. Dewan.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging (PHM043F) examines the current and future outlook of the global market, along with a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry. The report includes forecasted trends and revenue through 2019.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming(at)bccresearch(dot)com.
About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key market participants. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Recently selected as the world’s greatest market research company, BCC Research is a unit of Eli Global, LLC. Visit our website at http://www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern Time), or email information(at)bccresearch(dot)com.
Steven Cumming, BCC Research, http://www.bccresearch.com, +1 (781) 489-7301 Ext: 632, [email protected]
Share this article